Insider Transactions in Q1 2025 at Gemini Therapeutics, Inc. (GMTX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2025
|
Mona Ashiya Director |
SELL
Open market or private sale
|
Indirect |
5,738
-0.4%
|
$309,852
$54.11 P/Share
|
|
Mar 24
2025
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
5,738
-0.4%
|
$309,852
$54.11 P/Share
|
|
Mar 21
2025
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
10,011
-0.7%
|
$540,594
$54.0 P/Share
|
|
Mar 21
2025
|
Mona Ashiya Director |
SELL
Open market or private sale
|
Indirect |
10,011
-0.7%
|
$540,594
$54.0 P/Share
|
|
Mar 20
2025
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
2,762
-0.19%
|
$149,148
$54.01 P/Share
|
|
Mar 20
2025
|
Mona Ashiya Director |
SELL
Open market or private sale
|
Indirect |
2,762
-0.19%
|
$149,148
$54.01 P/Share
|
|
Mar 19
2025
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
39,656
-2.69%
|
$2,141,424
$54.02 P/Share
|
|
Mar 19
2025
|
Mona Ashiya Director |
SELL
Open market or private sale
|
Indirect |
39,656
-2.69%
|
$2,141,424
$54.02 P/Share
|
|
Mar 12
2025
|
Mona Ashiya Director |
SELL
Open market or private sale
|
Indirect |
83,182
-2.68%
|
$4,491,828
$54.74 P/Share
|
|
Mar 12
2025
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
83,182
-2.68%
|
$4,491,828
$54.74 P/Share
|
|
Mar 11
2025
|
Mona Ashiya Director |
SELL
Open market or private sale
|
Indirect |
27,056
-1.71%
|
$1,461,024
$54.01 P/Share
|
|
Mar 11
2025
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
27,056
-1.71%
|
$1,461,024
$54.01 P/Share
|
|
Mar 10
2025
|
Mona Ashiya Director |
SELL
Open market or private sale
|
Indirect |
202,146
-5.66%
|
$10,915,884
$54.65 P/Share
|
|
Mar 10
2025
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
202,146
-5.66%
|
$10,915,884
$54.65 P/Share
|
|
Feb 18
2025
|
Rahul Khara Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,161
-3.0%
|
$62,694
$54.58 P/Share
|
|
Feb 18
2025
|
Pamela Stephenson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,137
-4.32%
|
$169,398
$54.58 P/Share
|
|
Feb 18
2025
|
Jean M. Franchi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,136
-4.32%
|
$169,344
$54.58 P/Share
|
|
Feb 18
2025
|
Jonathan Yen Wen Yu Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,610
-3.82%
|
$86,940
$54.58 P/Share
|
|
Feb 18
2025
|
William Jacob Savage Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,638
-2.34%
|
$88,452
$54.58 P/Share
|
|
Feb 18
2025
|
John D Quisel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,574
-3.48%
|
$300,996
$54.58 P/Share
|
|
Feb 10
2025
|
Pamela Stephenson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,000
+33.13%
|
-
|
|
Feb 10
2025
|
Jonathan Yen Wen Yu Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+36.27%
|
-
|
|
Feb 10
2025
|
Rahul Khara Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+38.69%
|
-
|
|
Feb 10
2025
|
John D Quisel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,337
+32.81%
|
-
|
|
Feb 10
2025
|
Jean M. Franchi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,000
+33.13%
|
-
|
|
Feb 10
2025
|
William Jacob Savage Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+25.5%
|
-
|
|
Feb 03
2025
|
William Jacob Savage Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,731
+5.9%
|
$11,462
$2.65 P/Share
|
|
Feb 03
2025
|
Rahul Khara Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,500
-18.92%
|
$412,500
$55.71 P/Share
|
|
Feb 03
2025
|
Rahul Khara Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+25.83%
|
$105,000
$14.69 P/Share
|
|
Jan 02
2025
|
Rahul Khara Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,500
-13.19%
|
$472,500
$63.01 P/Share
|
|
Jan 02
2025
|
Rahul Khara Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+25.83%
|
$105,000
$14.69 P/Share
|